ǰÑÔ
²¡¶¾ÐÔ¸ÎÑ×(viral hepatitis)ÊÇÓɶàÖÖ²î±ð¸ÎÑײ¡¶¾ÒýÆðµÄÒ»×éÒÔ¸ÎÔàËðº¦ÎªÖ÷µÄѬȾ²¡£¬¿É·ÖΪ¼×¡¢ÒÒ¡¢±û¡¢¶¡¡¢Îì¡¢¸ýÁùÖÖÀàÐÍ£¬¸÷ÐÍÖ®¼äÎÞ½»Ö¯ÃâÒߣ¬¿Éͬʱ»òÏȺóѬȾ£¬»ìÏýѬȾ»òÖØµþѬȾ£¬Ê¹Ö¢×´¼ÓÖØ¡£¼×ÐͲ¡¶¾ÐÔ¸ÎÑ׺ÍÎìÐͲ¡¶¾ÐÔ¸ÎÑ×ÒԷࣿÚÈö²¥ÎªÖ÷£¬³£¼û·¢ÈÈ¡¢»Æ¾Ò£¬³Ê¼±ÐÔ¾ÓÉ£¬ÓÐÊýǨÑÓ³ÉÂýÐÔ£»ÒÒÐͲ¡¶¾ÐÔ¸ÎÑ׺ͱûÐͲ¡¶¾ÐÔ¸ÎÑ×£¬¶à¾ÊäѪ»òÑªÖÆÆ·ÒÔ¼°Ç×½ü½Ó´¥Èö²¥£¬Ò×ǨÑÓÉú³¤³ÉÂýÐÔÉõÖÁ¸ÎÓ²»¯£¬ÒÑ֤ʵÒÒÐͺͱûÐ͸ÎÑײ¡¶¾Ñ¬È¾Óë¸Î°©ÓÐÒ»¶¨¹ØÏµ£»¶¡ÐͲ¡¶¾ÐÔ¸ÎÑ×ÐèÒÀÀµÓÚÒÒÐ͸ÎÑײ¡¶¾¶ø±£´æ²¢¸´ÖÆ£¬³£ÓëÒÒÐ͸ÎÑײ¡¶¾³Ê»ìÏýѬȾ»òÔÚÒÒÐ͸ÎÑײ¡¶¾ÑôÐÔµÄÂýÐÔÒҸβ¡³ÌÖÐÖØµþѬȾ¡£ÏÖÔÚ½¨ÉèµÄ²¡¶¾ÐÔ¸ÎÑ×¶¯ÎïÄ£×ÓÖ÷ÒªÓм×Ð͸ÎÑײ¡¶¾Ä£×Ó¡¢ÒÒÐ͸ÎÑײ¡¶¾Ä£×Ó¡¢±ûÐ͸ÎÑ× ²¡¶¾Ä£×ÓºÍÎìÐ͸ÎÑײ¡¶¾Ä£×Ó¡£
±ûÐ͸ÎÑײ¡¶¾(hepatitis C virus,HCV)ÊÇÒ»µ¥¹ÉÕýÁ´RNA²¡¶¾£¬¿ÉÒýÆð¼±ÐÔºÍÂýÐÔ²¡¶¾ÐÔ±ûÐ͸ÎÑ×(hepatitis C)£¬¿ÉÉú³¤³É¸ÎÏËά»¯¡¢¸ÎÓ²»¯ÉõÖÁ¸Îϸ°û°©¡£HCV³ÊÈ«ÇòÐÔÊ¢ÐУ¬Æ¾Ö¤ÌìÏÂÎÀÉú×éÖ¯µÄͳ¼Æ£¬HCVÔÚÈËȺÖеÄѬȾÂÊԼΪ3%£¬È«ÇòÔ¼ÓÐ1.7ÒÚÈËѬȾHCV£¬Ã¿Äêз¢±ûÐ͸ÎÑײ¡ÀýÔ¼3.5ÍòÀý¡£ÎÒ¹ú¾ÙÐеÄÌìÏÂHCVѪÇåÊ¢Ðв¡Ñ§ÊÓ²ìÏÔʾ£¬ÎÒ¹úÒ»Ñùƽ³£ÈËȺ¿¹HCVÑôÐÔÂÊΪ3.2%£¬Ô¼ÓÐ4000ÍòÈËѬȾHCV¡£Ïà±ÈHBV£¬ÔÚÎÒ¹úHCVѬȾÊܵ½µÄÖØÊÓˮƽ»¹²»·ó¡£Ïà¹ØÑо¿Ò²ºÍÍâÑóÓнϴó²î±ð£¬±¾²¿·Ö¾ÍÏÖÔÚHCVÑо¿Óö¯ÎïÄ£×Ó×÷Ò»ÏÈÈÝ£¬¹©Ïà¹ØÁìÓòÑо¿Õ߲ο¼¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯ÎºÚÐÉÐÉ¡¢Ê÷üš¡¢´óÊó
¡¾ÔìÄ£»úÖÆ¡¿£º
±ûÐ͸ÎÑײ¡¶¾Èö²¥Í¾¾¶Óë°¬×̲¡¶¾ºÍÒҸβ¡¶¾ÏàËÆ£¬Ö÷Òª¾ÊäѪ¡¢Ä¸Ó¤ºÍÐÔÈö²¥£¬½«HCV»¼ÕßѪÇå»òϸ°û×÷ÓýµÄHCVcc¾²Âö×¢Éäµ½¶¯ÎïÌåÄÚ£¬ÓÕµ¼¶¯Îﱬ·¢ÀàËÆÓÚÈËÀà×ÔȻѬȾ±ûÐ͸ÎÑײ¡¶¾ºóµÄ¼²²¡Àú³Ì¡£
¡¾ÔìÄ£ÒªÁì¡¿£º
ºÚÐÉÐÉ(pan troglodytes)£ºÓÃHCV»¼ÕßÑªÖÆÆ·Í¨¹ý¾²Âö×¢ÉäºÚÐÉÐÉ£¬»ò½«ÌåÍâ×ªÂ¼ÖÆ±¸µÄHCV RNA×¢Éäµ½ºÚÐÉÐɸÎÔàÖУ¬¿ÉʹºÚÐÉÐÉѬȾHCV²¡¶¾¡£ºÚÐÉÐÉѬȾHCVºó·ºÆðת°±Ã¸Éý¸ß£¬¸Î»î¼ì·ºÆð¼±ÐÔ»µËÀÐÔÑ×Ö¢¸Ä±ä¡£
Ê÷üš£ºÓÃHCV»¼ÕßѪÇå»òϸ°û×÷Óý»ñµÃµÄHCV²¡¶¾(HCVcc)ͨ¹ý¾²Âö»ò¸ÎÔà¶àµã×¢Éä·½·¨×¢Éäµ½Ê÷üšÌåÄÚ£¬¿ÉʹÊ÷üšÑ¬È¾HCV²¢·ºÆð¼äЪÐÔ²¡¶¾ÑªÖ¢¡£
´óÊ󣺽«ÈËÔ´ú¸Îϸ°ûijÈ˸ΰ©Ï¸°ûHuh7¸¹Ç»×¢Éäµ½ÔÐÁäÔÚ15~17ÌìµÄÌ¥ÊóÖУ¬²¢ÔÚ³öÉú24СʱÄÚÏòÆäÒÆÖ²ÈËÔ´ú¸Îϸ°û»òHuh7£¬Ê¹Ì¥ÊóµÄÃâÒßϵͳÔÚ·¢ÓýÀú³Ì»ñµÃ¶ÔÕâЩϸ°ûµÄÃâÒßÄÍÊÜ£¬ËæºóÏò´óÊó½ÓÖÖ´Ó»¼ÕßѪÇåÊèÉ¢µ½µÄHCV£¬¿ÉʹÆä»ñµÃ¶ÔHCVµÄѬȾÐÔ¡£
¡¾Ä£×ÓÌØµã¡¿£º
ºÚÐÉÐÉÊÇHCVµÄ×ÔÈ»ËÞÖ÷£¬ÔÚѬȾHCVºó¿ÉÒÔ×ÔȻɨ³ý²¡¶¾£¬ÂýÐÔЯ´øÕß²»»áÉú³¤Îª¸ÎÓ²»¯»ò¸ÎÏËά»¯£¬²¢¶Ô×ÌÈÅËØÖÎÁÆÎÞЧ¡£ºÚÐÉÐÉѬȾHCVºóÖ»ÓиöÌå±»±¨µÀ×îºóÉú³¤Îª¸Îϸ°û¸Î°©¡£
Ê÷üšÑ¬È¾HCVÄܱ¬·¢Ë²Ê±²¡¶¾ÑªÖ¢£¬HCV¿¹Ìå¡¢ALT¡¢HCV RNAÑôÐÔ¡£ÑôÐÔÊ÷üšµÄѪ½¬Í¬Ñù¿ÉÒÔѬȾÐÂÊ÷üš£¬Ê÷üšÑ¬È¾HCVºó¸ÎÀïÖ¯²¡Àí¸Ä±äÀú³ÌÓëÈËÀà±ûÐ͸ÎÑ×µÄÏ£ÍûÒ»Ö£¬¼´ÂýÐÔ¸ÎÑ×→¸ÎÖ¬·¾±ä→¸ÎÓ²»¯→¸Î°©¡£Í¼7-1/ÎÄÄ©²Êͼ7-1ʾÊ÷üšÑ¬È¾HCVºó¸ÎÔಡÀí¸Ä±äÇéÐΡ£
´óÊóÔÚHCVѬȾ4ÖܺóÔÚѪÇåÖпɼì²âµ½7.0×103¿½±´Êý£¯ml HCV RNA, 12ÖܺóHCV RNAµÖ´ï·åÖµ20×103¿½±´Êý£¯ml£¬Ö®ºó×îÏÈϽµ¡£±û°±Ëá°±»ù×ªÒÆÃ¸ÔÚ4ÖÜ×îÏÈÉý¸ß£¬µÚ13ÖÜÃÜ´ïá¯Á룬֮ºó×îÏÈϽµ¡£ÏÔ΢¾µÏ¿ɼû¸ÎÃźÍÖÐÑëÇøÓòµ¥ºËϸ°û½þÈó¡£
ͼ7-1 Ê÷üšÑ¬È¾HCVºó¸ÎÔಡÀí¸Ä±äÇéÐÎ
×¢£ºA£®±ÈÕÕ×飺Õý³£¸Î×éÖ¯(H&E×400);B-F£®Ê÷ÔÏѬȾHCVºó¸ÎÔಡÀíѧ¸Ä±ä£»B£®Ö¬·¾±äÐÔ¡¢µ¨ÖÓÙ»ý(H&E×200);C£®¸Îϸ°û¿ÕÅÝÑù±äÐÔ(H&E×400); D£®µ¨¹ÜËðÉË£¬°é»ã¹ÜÇøÂýÐÔÑ×ϸ°û½þÈó(H&E×200);E£®ÃâÒß×黯HCV¿¹Ô°ûÖÊÑôÐÔ(×400);F£®ÃâÒß×黯HCV¿¹Ô°ûÖÊÆ¬Ôî×´ÑôÐÔ(×200)
¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º
ºÚÐÉÐÉÊÇÏÖÔÚ³ýÈËÀàÍâΨһ¿ÉÒÔ±»HCVѬȾµÄÁ鳤ÀදÎºÚÐÉÐÉѬȾHCV£¬ÆäÁÙ´²Àú³ÌÓëÈËÀàHCVѬȾÏàËÆ£¬²¢Äܹ»ÐγÉÂýÐÔѬȾ£¬ÂýÐÔЯ´øÕß²»»áÉú³¤Îª¸ÎÓ²»¯»ò¸ÎÏËά»¯¡£¿ÉÒÔÓÃÓÚÑо¿HCVµÄ¼±ÐÔѬȾ£¬Ñо¿ÔÚ¼±ÐÔÆÚÄÚHCVµÄ²¡¶¾Ñ§×ª±äºÍËÞÖ÷µÄÃâÒß·´Ó¦£»Ñо¿HCV×ÔȻѬȾÀú³ÌÖв¡Àíѧ¡¢ÃâÒß·´Ó¦µÈ·½ÃæµÄת±äºÍHCVÒßÃçµÄÑз¢¡£µ«ºÚÐÉÐɲ»ÊʺÏÑо¿ÂýÐÔѬȾºÍÓëHCVÏà¹ØµÄ¸Îϸ°û¸Î°©¡£ÏÖÔÚ£¬NIH ÒѾեȡÔÚÉúÎïҽѧÑо¿ÖÐʹÓúÚÐÉÐÉ¡£
Ê÷üšÊÇÒ»ÖÖÓÐÔ¶¾°µÄHCV¶¯ÎïÄ£×Ó£¬ÒÅ´«½ø»¯ÉϱÈСÊó¡¢¼ÒÍõȸü¿¿½üÁ鳤ÀࡣѬȾHCVºó£¬Äܱ¬·¢Ë²Ê±²¡¶¾ÑªÖ¢£¬HCV¿¹Ìå¡¢ALT¡¢HCV RNAÑôÐÔ¡£¿ÉÓÃÓÚÑо¿HCVÈëÇֺ͸´ÖÆ»úÖÆ¡£
´óÊóÄ£×Ó»ñµÃµÄ¶¯ÎïÊÇÃâÒß¹¦Ð§Õý³£µÄ´óÊó£¬ ¿ÉÓÃÓÚÑо¿HCVµÄÈëÇÖ¡¢¸´ÖÆ¡¢ÃâÒ߽鵼µÄ¸ÎËðÉ˺Í×÷ΪҩÎïɸ²éµÄ¹¤¾ß£¬µ«ÓÉÓÚÌåÄÚÒÆÖ²µÄÈ˸ΰ©Ï¸°ûÊýÄ¿ÓÐÏÞ£¬HCVѬȾºó²¡¶¾ÔØÁ¿µÍ£¬Ò²ÏÞÖÆÁËÆäÓ¦Óá£
²Î¿¼ÎÄÏ×£º
1.Äϴ󺽣¬ÅËÄþ£¬ÕލÇí£®ÒÒÐ͸ÎÑ×¶¯ÎïÄ£×ÓÑо¿Ï£Íû. ¶«ÄÏ´óѧѧ±¨£¨Ò½Ñ§°æ£©£¬2012, 31 (4):504-507
2.¹¢¼Ò±¦£¬ÍõÁᣬÖìÓÀºì£®ÊµÑéѬȾÎìÐ͸ÎÑײ¡¶¾¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®ÖйúÔ¤·ÀҽѧÔÓÖ¾£¬2010, 11(4):429-432
3.Õ²ÃÀÔÆ£¬Áõ³ç°Ø£¬Àî³ÉÃ÷£¬µÈ£®¼×Ð͸ÎÑײ¡¶¾Ñ¬È¾Ê÷üšµÄÆðÔ´Ñо¿£®Öйúҽѧ¿ÆÑ§ÔºÑ§±¨£¬1981, 3 (3):148-152
4.Amado LA, Marchevsky RS,de Paula VS, el al. Experimental hepatitis A virus (HAV) infection in cynomolgus monkeys (Macaca fascicularÐÄ£ºevidence of active exlranepaticsite of HAV replication.Int J Exp Pathol, 2010, 91 (1):87-97
5.Dand.ri M, Burda MR, Torok E, et al. Repopulation of mouse Liver with human hepatocytes and in vivo infection wilh hepatilis B virus. Hepatology, 2001, 33 (4):981-988
6.Dorner M,Horwilz JA,Robbins JB,el al. A genetically humanized mouse model for hepatitis C virus Infection.Nature,2011,474(7350):208-211
7.Maneeral. Y, Clayson ET, Myint KS, et al. Experimental infection of the lahoratory rat with the hepatitis e virus. J Med Virol, 1996,48 (2): 121-128
8.Purcell RH, Emerson SU. Emerson. Animal Models of Hepatitis A and E. ILAR J, 2001, 42 (2): 161-177